These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5905463)

  • 1. Mitomycin-C in the therapy of far-advanced malignant tumors.
    Manheimer LH; Vital J
    Cancer; 1966 Feb; 19(2):207-12. PubMed ID: 5905463
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
    Gary-Bobo J
    J Radiol Electrol Med Nucl; 1971 Dec; 52(12):858-62. PubMed ID: 4113798
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous intravenous infusions of 5-fluoro-2'-deoxyuridine in the treatment of solid tumors.
    DeConti RC; Kaplan SR; Papac RJ; Calabresi P
    Cancer; 1973 Apr; 31(4):894-8. PubMed ID: 4267531
    [No Abstract]   [Full Text] [Related]  

  • 4. [On intralymphatic administration of antineoplastic agents].
    Porzio R; Giannattasio G; Carbone R; Di Stefano G
    Minerva Med; 1970 May; 61(43):2405-16. PubMed ID: 5425727
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of cancer with weekly intravenous 5-fluorouracil.
    Jacobs EM; Luce JK; Wood DA
    Cancer; 1968 Dec; 22(6):1233-8. PubMed ID: 5705785
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I-II evaluation of weekly mitomycin-C (NSC-26980) for patients with metastatic GI and breast malignancies.
    Hum GJ; Bogdon DL; Bateman JR
    Oncology; 1974; 30(3):236-43. PubMed ID: 4459738
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracavitary thiotepa in malignant pleural and peritoneal effusions.
    Andersen AP; Brincker H
    Acta Radiol Ther Phys Biol; 1968 Oct; 7(5):369-78. PubMed ID: 4981030
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausmans R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):641-53. PubMed ID: 4895427
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigational and practical chemotherapy of solid tumors.
    Talley RW
    Geriatrics; 1970 Oct; 25(10):113-25. PubMed ID: 5528232
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitomycin-C therapy in advanced gastrointestinal malignant tumours.
    Vaidya MP; Prasad CN; Roy SK; Singh HN
    Indian J Cancer; 1974 Sep; 11(3):255-61. PubMed ID: 4140845
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of solid tumours.
    World Health Organ Tech Rep Ser; 1977; (605):1-106. PubMed ID: 407727
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
    Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
    Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
    [No Abstract]   [Full Text] [Related]  

  • 13. [218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
    Israel L; Bernard E
    Poumon Coeur; 1968; 24(1):63-8. PubMed ID: 5690023
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer chemotherapy.
    Smith LH
    Major Probl Intern Med; 1971; 1():1-197. PubMed ID: 5005758
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
    Krauss S; Sonoda T; Solomon A
    Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitomycin C therapy in advanced gastrointestinal cancer.
    Moertel CG; Reitemeier RJ; Hahn RG
    JAMA; 1968 Jun; 204(12):1045-8. PubMed ID: 5694750
    [No Abstract]   [Full Text] [Related]  

  • 17. Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
    Nathanson L; Hall TC; Schilling A; Miller S
    Cancer Res; 1969 Feb; 29(2):419-25. PubMed ID: 4885390
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitomycin: ten years after approval for marketing.
    Doll DC; Weiss RB; Issell BF
    J Clin Oncol; 1985 Feb; 3(2):276-86. PubMed ID: 3881563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations with 1,4-bis-(2'-mesyloxyethylamino)-1,4-dideoxy-meso-erythritol (R-74).
    Hindy I; Sellei C; Eckhardt S; Szentklãray J; Hartai F
    Neoplasma; 1971; 18(3):277-82. PubMed ID: 4937513
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with mitomycin C in large infrequent doses.
    Godfrey TE; Wilbur DW
    Cancer; 1972 Jun; 29(6):1647-52. PubMed ID: 5064044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.